239 related articles for article (PubMed ID: 2565807)
1. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
[TBL] [Abstract][Full Text] [Related]
2. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.
Lee J; Dull TJ; Lax I; Schlessinger J; Ullrich A
EMBO J; 1989 Jan; 8(1):167-73. PubMed ID: 2565808
[TBL] [Abstract][Full Text] [Related]
3. A chimeric EGFR/neu receptor in studies of neu function.
Lehtola L; Lehväslaiho H; Koskinen P; Alitalo K
Cancer Treat Res; 1992; 61():213-28. PubMed ID: 1360234
[No Abstract] [Full Text] [Related]
4. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
6. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
Stern DF; Heffernan PA; Weinberg RA
Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
[TBL] [Abstract][Full Text] [Related]
7. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase.
Lehväslaiho H; Sistonen L; diRenzo F; Partanen J; Comoglio P; Hölttä E; Alitalo K
J Cell Biochem; 1990 Mar; 42(3):123-33. PubMed ID: 1969420
[TBL] [Abstract][Full Text] [Related]
8. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
Sistonen L; Hölttä E; Lehväslaiho H; Lehtola L; Alitalo K
J Cell Biol; 1989 Nov; 109(5):1911-9. PubMed ID: 2572601
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
10. The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor.
Pandit SD; Donis-Keller H; Iwamoto T; Tomich JM; Pike LJ
J Biol Chem; 1996 Mar; 271(10):5850-8. PubMed ID: 8621456
[TBL] [Abstract][Full Text] [Related]
11. The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS
Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
Di Fiore PP; Kraus MH
Cancer Treat Res; 1992; 61():139-60. PubMed ID: 1360229
[No Abstract] [Full Text] [Related]
13. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene.
Lev S; Yarden Y; Givol D
Mol Cell Biol; 1990 Nov; 10(11):6064-8. PubMed ID: 1700279
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.
Riedel H
J Virol; 1994 Jan; 68(1):411-24. PubMed ID: 8254751
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.
Lehtola L; Nistér M; Hölttä E; Westermark B; Alitalo K
Cell Regul; 1991 Aug; 2(8):651-61. PubMed ID: 1685673
[TBL] [Abstract][Full Text] [Related]
16. A chimeric EGFR/neu receptor in functional analysis of the neu oncoprotein.
Lehtola L; Lehväslaiho H; Koskinen P; Alitalo K
Acta Oncol; 1992; 31(2):147-50. PubMed ID: 1352454
[TBL] [Abstract][Full Text] [Related]
17. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
Guy PM; Carraway KL; Cerione RA
J Biol Chem; 1992 Jul; 267(20):13851-6. PubMed ID: 1352772
[TBL] [Abstract][Full Text] [Related]
18. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
Reardon DB; Hung MC
J Biol Chem; 1993 Aug; 268(24):18136-42. PubMed ID: 7688739
[TBL] [Abstract][Full Text] [Related]
19. Receptor downregulation and DNA synthesis are modulated by EGF and TPA in cells expressing an EGFR/neu chimera.
Lehtola L; Lehväslaiho H; Sistonen L; Beguinot L; Alitalo K
Growth Factors; 1989; 1(4):323-34. PubMed ID: 2699432
[TBL] [Abstract][Full Text] [Related]
20. Cloning and activation of the Syrian hamster neu proto-oncogene.
Nakamura T; Ushijima T; Ishizaka Y; Nagao M; Arai M; Yamazaki Y; Ishikawa T
Gene; 1994 Mar; 140(2):251-5. PubMed ID: 7908275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
